Dudediligence.

Daré Bioscience, Inc

DARENASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$41,691Sep ’24−$63,647Dec ’24$25,427Mar ’25$2,262Sep ’25$1.0MDec ’25$152,455Mar ’26$187,546Jun ’26
Net income, by quarter
−$4.7MSep ’24−$5.5MDec ’24−$4.4MMar ’25−$4.0MJun ’25−$3.6MSep ’25−$1.4MDec ’25−$3.0MMar ’26−$3.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00$10.0M$2.8M$9,784$1.0M
Gross profitnone on filenone on filenone on file$9,784$734,394
Operating income−$39.1M−$31.4M−$30.9M−$23.5M−$13.6M
Net income−$38.7M−$30.9M−$30.2M−$4.1M−$13.4M
Operating cash flow−$28.8M−$18.1M−$38.9M$5.5M−$9.9M
Free cash flow−$28.8M−$18.2M−$39.5M$4.9M−$10.3M
Cash$51.7M$34.7M$10.5M$15.7M$24.7M
Shares outstanding83.9M84.8M8.3M8.7M14.5M